Gain Therapeutics

Developer of chaperon based therapy for rare lysosomal storage diseases

placeLugano, Ticino, Switzerland calendar_todayFounded 2017 groups31 employees language gaintherapeutics.com

Registered entities

Social engagement

Social engagement: 6.7K social following, 7 posts in the last 12 months — above the industry median.

Investor mix

8 investors on record; lead investors include TiVentures, 3B Future Health Fund.

Investor typeCountShare
Venture capital338%
Private equity113%
Other / undisclosed450%

Recent activity

10 Jun 2026
Event
H.C. Wainwright & Co., LLC 7th Annual Neuro Perspectives Expert Summit
24 Apr 2026
Event
3rd International GBA1 Canada (G-Can) Initiative Meeting 2026
Coming soon